Sarcopenia and postoperative outcomes in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Abdominal Radiology · 2026
DOI: 10.1007/s00261-026-05393-5 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Abdominal Radiology, 2026. Verfasst von Manuela Gallo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Fundación Santa Fe de Bogotá, Bogotá, Colombia. Hauptthemen laut MEDLINE: Peritoneal Neoplasms, Sarcopenia, Cytoreduction Surgical Procedures, Hyperthermic Intraperitoneal Chemotherapy. Die Arbeit nennt 24 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE: To determine the association between preoperative computed tomography (CT)-measured sarcopenia and short-term postoperative outcomes in patients with peritoneal carcinomatosis (PC) undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC). In addition, specific objectives included determining the prevalence of sarcopenia, evaluating the association of postoperative prognosis and outcomes, and assessing the prevalence of postoperative complications in this population undergoing CRS-HIPEC. MATERIALS AND METHODS: Retrospective observational study included patients with PC undergoing CRS + HIPEC at a specialized center. Sarcopenia was assessed on preoperative CT using the skeletal muscle index (SMI) at the L3 level. Postoperative outcomes and survival were analyzed using standard univariable and multivariable statistical methods. RESULTS: No significant differences in short-term postoperative outcomes were observed between sarcopenic and non-sarcopenic patients. Overall survival did not differ significantly between groups. However, sarcopenia was independently associated with shorter disease-free survival (DFS) and a higher risk of recurrence. CONCLUSION: Sarcopenia was independently associated with shorter DFS and a higher risk of recurrence, supporting its role as a prognostic marker rather than a driver of perioperative morbidity. Preoperative identification may improve risk stratification and guide long-term follow-up, while prospective studies are needed to determine whether targeted interventions can improve outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
- Department of Radiology, Massachusetts General Hospital, 55 Fruit St, Boston, MA, 02114, USA.
- Pediatric Imaging Research Center, Massachusetts General Hospital, Boston, MA, USA.
- Department of Radiology, Harvard Medical School, Boston, MA, USA.
- Department of Radiology, Fundación Santa Fe de Bogotá, Bogotá, Colombia. lauraolbe@unisabana.edu.co.
- Department of Surgery, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Zitieren
APA
Gallo, M., Valencia, S., Olarte-Bermúdez, L. M., Arias-Amézquita, F., Londoño-Schimmer, E., Otero, J., Cétares, C., & Aguirre, D. A. (2026). Sarcopenia and postoperative outcomes in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Abdominal Radiology. https://doi.org/10.1007/s00261-026-05393-5
Vancouver
Gallo M, Valencia S, Olarte-Bermúdez LM, Arias-Amézquita F, Londoño-Schimmer E, Otero J, et al. Sarcopenia and postoperative outcomes in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Abdominal Radiology. 2026. doi:10.1007/s00261-026-05393-5
BibTeX
@article{Gallo2026,
author = {Gallo, Manuela and Valencia, Sergio and Olarte-Bermúdez, Laura Manuela and Arias-Amézquita, Fernando and Londoño-Schimmer, Eduardo and Otero, Jorge and Cétares, Camilo and Aguirre, Diego Andrés},
title = {Sarcopenia and postoperative outcomes in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy},
journal = {Abdominal Radiology},
year = {2026},
doi = {10.1007/s00261-026-05393-5}
}
EUVIMED